June 23 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* Health Canada has approved Simponi for treatment of adults
with severe active non-radiographic axial spondyloarthritis
Source text for Eikon: ID:nCNWtvkQqa
Further company coverage: JNJ.N
(Bengaluru Newsroom: +1-646-223-8780) June 23 (Reuters) - Janssen Inc:
* Health canada has approved Simponi for treatment of adults
with severe active non-radiographic Axial Spondyloarthritis
Source text for Eikon: ID:nCNWtvkQqa
Further company coverage: JNJ.N
(Bengaluru Newsroom: +1 646 223 8780)